Skip to main content
Earnings Labs
Inhibikase Therapeutics, Inc. logo

Inhibikase Therapeutics, Inc. (IKT) Earnings

NASDAQ·Healthcare·Biotechnology

$2.29

+3.39%

Mkt Cap $287.83M

EPS — Estimate vs Actual

Mkt Cap

$287.83M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$0.54